Malaghan Institute Of Medical Research

This phase 2 trial tests a new CAR T-cell therapy called WZTL-002 for people with large B-cell lymphoma that has returned or not responded to standard treatment. About 60 participants will receive the therapy after a short course of chemotherapy. Researchers will track how many a…